Massive pleural effusion and ascites resulting from esophagectomy with extensive lymphadenectomy for cancer of the abdominal esophagus

Hepato-Gastroenterology

Volumn 46, Issue 25, 1999, Pages 290-294

  Fujiwara, Yoshinori ^a   Nakagawa, Kazuhiko ^a   Kusunoki, Masato ^a   Hatada, Takuya ^a   Yamamura, Takehira ^a   Utsunomiya, Joji ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Chylothorax; Esophagectomy

Indexed keywords

ANTINEOPLASTIC AGENT; MINOCYCLINE; PICIBANIL; TETRACYCLINE DERIVATIVE;

ADULT; ARTICLE; ASCITES; CANCER SURGERY; CASE REPORT; CHYLOTHORAX; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; HUMAN; LYMPHADENECTOMY; MALE; PATHOPHYSIOLOGY; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; THORACOTOMY;

ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; ASCITES; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; MINOCYCLINE; PICIBANIL; PLEURAL EFFUSION;

EID: 0033039729     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. 1 Ide H, Eguchi A, Nakamura T, Hayashi K, Yoshida K, et al: Extended three field lymphadenectomy for lymph nodes metastasis of upper mediastinum of cancer of the thoracic esophagus. The Journal of the Japanese Association for Thoracic Surgery 1994; 42:737-738. (In Japanese)
2. 2 Hirayama K, Nishihira T, Akaishi T, Hyoba R, Katayama M, et al: The technique and results of the extended lymphadenectomy of the neck and upper mediastinum for cancer of the thoracic esophagus. The Journal of the Japanese Association for Thoracic Surgery 1994; 42:739-740. (In Japanese)
3. 3 Isono K, Sato H, Nakayama K: Results of a nation wide study on the three field lymph nodes dissection of esophageal cancer. Oncology 1991; 48:411-420.
4. 4 Griffin SM, Woods SDS, Chan A, Chung SCS, Li AKC: Early and late surgical complications of subtotal esophagectomy for squamous carcinoma of the esophagus, JR Coll Surg Edinb 1991; 36:170-173.
5. 5 Eeftinck ME, Obertop H, Mud HJ, Eijkenboom WMH, Van Andel JG, Van Houten H: Survival after resection for carcinoma of the esophagus. Br J Surg 1987; 75:165-168.
6. 6 Giuli R, Cignoux M: Treatment of carcinoma of the oesophagus. Retrospective study of 2400 patients. Ann Surg 1980; 192:44-52.
7. 7 Wong J: Stapled esophagogastric anastomosis in the apex of the right chest after subtotal esophagectomy for cancer. Surg Gynecol Obstet 1987; 164:568-572.
8. 8 Lampson RS: Traumatic chylothorax: a review of the literature and report of a case treated by mediastinal ligation of the thoracic duct. J Thorac Surg 1948; 17:778-790.
9. 9 Akaogi K, Mitsui K, Sohara Y, Endo S, Ishikawa S, Hori M: Treatment of postoperative chylothorax with intrapleural fibrin glue. Ann Thorac Surg 1989; 48:116-118.
10. 10 Robinson GLH: The management of chylothorax (Collective review). Ann Thorac Surg 1985; 39:90-95.
11. 11 Cha EM, Sirijintakarn P: Anatomical variation of the thoracic duct and visualization of mediastinal lymph nodes. Diagnostic Radiology 1976; 119:45-48.
12. 12 Van Pernis PA: Variation of the thoracic duct. Surgery 1949; 26:806-809.
13. 13 Blalock A, Robinson CS, Cunningham RS, et al: Experimental studies on lymphatic blockage. Arc Surg 1937; 34:1049-1071.
14. 14 Magari S: Surgical anatomy of the cisterna chyli and thoracic duct. Surgery 1986; 48:560-564. (In Japanese)
15. 15 Robinson CLN: The management of chylothorax, Ann Thorac Surg 1985; 39:90-95.
16. 16 Dougenis D, Walker WS: Management of chylothorax complicating extensive esophageal resection. Surgery, Gynecology & Obstetrics 1992; 174:501-506.
17. 17 Bolger C, Walsh TN, Tanner WA, Keeling P, Hennessy TPJ: Chylothorax after esophagectomy. Br J Surg 1991; 78:587-588.
18. 18 Milsom JW, Kron IL, Rheuban KS, Rodgers BM: Chylothorax: An assessment of current surgical management, J Thorac Cardiovasc Surg 1985; 89:221-227.
19. 19 Marts BC, Naunheim KS, Fiore AC, Pennington DG: Conservative versus surgical management of chylothorax. The American Journal of Surgery 164:532-535.
20. 20 Adler RH, Levinsky L: Persistent chylothorax. J Thorac Cardiovasc Surg 1978; 76:859-864.
21. 21 Kimura I, Ohnishi T, Yasuhara S, Sugiyama M, Urabe Y, Fujii M, Machida K: Immunochemotherapy in human lung cancer using the streptococcal agent OK-432. Cancer 1976; 37:2201-2203.
22. 22 Uchida A, Hoshino T: Clinical studies on cell mediated immunity in patients with malignant disease. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro. Cancer 1980; 45:476-483.
23. 23 Ishi Y, Yamaoka H, Toh K, Kikuchi K: Inhibition of tumor growth in vitro and in vivo by macrophages from rats treated with a streptococcal preparation OK-432. Gann 1976; 67:115-119. (In Japanese)
24. 24 Ono T, Kurata S, Wakabayashi K, Sugawara Y, Saito M, Ogawa H: Inhibitory effect of a streptococcal preparation (OK-432) on the nucleic acid synthesis in tumor cells in vitro. Gann 1973; 64:59-69. (In Japanese)
25. 25 Nakao A, Kato M, Watanabe T, Kawai N, Ota H, et al: OK-432 Chemical pleurodesis for the treatment of persistent chylothorax. Hepato-Gastroenterol 1994; 41:568-570.
26. 26 Saito H, Tsunezuka Y: Postpneumonectomy chylothorax successfully treated with intrathoracic injection of OK-432 autologous blood and thrombin: a report of two cases. The Journal of the Japanese Association for Chest Surgery 1994; 8:208-212. (In Japanese)
27. 27 Patterson GA, Todd TRJ, Delarue NC, Ilves R, Pearson FG, Cooper JD: Supradiaphragmatic ligation of the thoracic duct in intractable chylous fistula. Ann Thorac Surg 1981; 32:44-49.